# OnCo record paper-eau-nmibc-guideline-eur-urol-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-eau-nmibc-guideline-eur-urol-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-eau-nmibc-guideline-eur-urol-2022" ;
  schema:name "European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1 and carcinoma in situ)"@en ;
  schema:description "The European urology guideline sets out how to diagnose, resect, risk-group and treat bladder cancers that have not reached the muscle, including when BCG is needed and when to remove the bladder."@en ;
  schema:url <https://onco.cc/key-papers/paper-eau-nmibc-guideline-eur-urol-2022/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.eururo.2021.08.010>, <https://pubmed.ncbi.nlm.nih.gov/34511303/> ;
  schema:sameAs <https://doi.org/10.1016/j.eururo.2021.08.010> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Babjuk M, Burger M, Capoun O, et al." ;
  onco:cancers <https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/> ;
  onco:journals <https://onco.cc/journals/european-urology/> .
